Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: phase II Randomized Control Clinical Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is an randomized controlled, multicenter clinical trial. The purpose of this study is to evaluate acute toxicity and efficacy of concurrent cisplatin chemoradiation with or without capecitabine as adjuvant chemotherapy in local advanced high risk nasopharyngeal carcinoma.
Epistemonikos ID: c7b6b221539e0fc58de0eddef3ef2d5dff834c6a
First added on: May 11, 2024